|
|
|
|
|
Delaware
|
|
001-36399
|
|
42-1560076
|
(State or other jurisdiction
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
of incorporation)
|
|
|
|
|
1900 Powell Street, Suite 1000
Emeryville, CA
|
|
94608
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
Name
|
|
Title
|
|
2019 Annual Base Salary
|
|
2018 Cash Bonus
|
Gregory T. Went, Ph.D.
|
|
President and Chief Executive Officer
|
|
550,000
|
|
260,200
|
Alfred G. Merriweather
|
|
Chief Financial Officer
|
|
430,000
|
|
180,600
|
Rajiv Patni
|
|
Chief Medical Officer
|
|
441,000
|
|
200,600
|
Jennifer J. Rhodes
|
|
Chief Business Officer and General Counsel
|
|
424,000
|
|
193,000
|
Name
|
|
Title
|
|
Stock Options
|
|
RSUs
|
Gregory T. Went, Ph.D.
|
|
President and Chief Executive Officer
|
|
112,500
|
|
56,250
|
Alfred G. Merriweather
|
|
Chief Financial Officer
|
|
50,000
|
|
25,000
|
Rajiv Patni
|
|
Chief Medical Officer
|
|
60,000
|
|
30,000
|
Jennifer J. Rhodes
|
|
Chief Business Officer and General Counsel
|
|
60,000
|
|
30,000
|
|
|
Adamas Pharmaceuticals, Inc.
|
|
|
|
|
|
Dated:
|
April 10, 2019
|
By:
|
/s/ Jennifer J. Rhodes
|
|
|
|
Jennifer J. Rhodes
|
|
|
|
Chief Business Officer and General Counsel
|